Skip to main content

dual specificity tyrosine phosphorylation regulated kinase 1A

The DYRK1A gene provides instructions for making an enzyme that is important in the development of the nervous system. The DYRK1A enzyme is a kinase, which means that it adds a cluster of oxygen and phosphorus atoms (a phosphate group) to other proteins through a process called phosphorylation. Phosphorylation of proteins helps to control (regulate) their activity.

Video picks for Genes
Video library

Normal function

The DYRK1A gene provides instructions for making an enzyme that is important in the development of the nervous system. The DYRK1A enzyme is a kinase, which means that it adds a cluster of oxygen and phosphorus atoms (a phosphate group) to other proteins through a process called phosphorylation. Phosphorylation of proteins helps to control (regulate) their activity.

The proteins whose activity the DYRK1A enzyme helps regulate are involved in various processes in cells, including cell growth and division (proliferation) and the process by which cells mature to carry out specific functions (differentiation). In nerve cells (neurons), the DYRK1A enzyme is involved in the formation and maturation of dendritic spines from dendrites. Dendrites are specialized extensions from neurons that are essential for the transmission of nerve impulses. Dendritic spines are small outgrowths from dendrites that further help transmit nerve impulses and increase communication between neurons.

Conditions referring to this gene or chromosome

Other names

dual specificity tyrosine-(Y)-phosphorylation regulated kinase 1A

dual specificity YAK1-related kinase

DYRK

DYRK1

HP86

MNB

mnb protein kinase homolog hp86

MNB/DYRK protein kinase

MNBH

MRD7

protein kinase minibrain homolog

serine/threonine kinase MNB

serine/threonine-specific protein kinase

Related patient information and medicines

Kidney cancer

Patient information leaflet

Kidney cancer

Immunotherapy (sometimes called biological therapy) and targeted molecular therapies Immunotherapy using interferon and aldesleukin (sometimes called interleukin 2) was commonly used to treat kidney cancer. They are types of medicines called multikinase inhibitors which interfere with the growth of cancer cells. In 2022, NICE recommended that a.

Chronic myeloid leukaemia

Patient information leaflet

Chronic myeloid leukaemia

Treatment for the initial chronic phase The aim of treatment is to control the disease process, to ease any symptoms and to prevent (or delay) the progress... You may be advised to have one or more of the following treatments: Imatinib tablets. This medicine is known as a tyrosine kinase inhibitor. The chemical tyrosine kinase is made by the.

Mastocytosis and mast cell disorders

Patient information leaflet

Mastocytosis and mast cell disorders

If the condition is severe, surgery to remove the spleen (splenectomy), medicines that have an effect on ... Dr Sarah Jarvis , 28th September 2021 Midostaurin for treating advanced systemic mastocytosis The National Institute for Health and Care Excellence (NICE) has brought out new guidance on the use of midostaurin for people with mastocytosis..

Mouth cancer

Patient information leaflet

Mouth cancer

Dia... Dr Krishna Vakharia , 16th October 2023 The National Institute for Health and Care Excellence (NICE) has recommended that a person should receive a diagnosis or ruling out of cancer within 28 days of being referred urgently by their GP for suspected cancer. To confirm the diagnosis It is likely that you will need a biopsy. Cetuximab is an.

Albinism

Patient information leaflet

Albinism

Albinism is a rare inherited (genetic) condition which reduces the amount of of melanin pigment in the skin, hair and/or eyes. People with albinism are often pale, with light-coloured irises. However, there are many types of albinism and people can be affected to different degrees. Although vision is usually severely i... People with albinism have.

Cardiac enzymes

Patient information leaflet

Cardiac enzymes

Cardiac enzymes are substances released by the heart muscle when it is injured - for example, during a heart attack or a severe case of angina. A heart attack (myocardial infarction) can present in many ways, the most common of which is chest pain. Taking blood tests for heart enzymes can help medical professionals to diagnose a heart attack. What.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 10 Apr 2023 | Latest version
  • 1 Jun 2017 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.